From these results, one could speculate that liver fat reduction may not necessarily precede the improvements in hepatic insulin resistance, given that fasting insulin, and to some extent also FGF-21, may partly reflect changes in hepatic insulin sensitivity. The gene discussed is INS; the disease is Insulin resistance.